Cubit Diagnostics Closes SAFE Financing to Advance Molecular Assay Development and Expand Immunoassay Menu
Cubit Diagnostics today announced it has closed its latest round of SAFE (Simple Agreement for Future Equity) financing. The proceeds will fund the company's next phase of work, centered on locking in design freeze for its molecular CT/NG/TV assay and expanding its immunoassay program.
